(Q39791528)

14 September 2017

1 reference

title

Biogenic amine hypotheses of affective disorders (English)

2 references

14 September 2017

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A372718

reason for preferred rank

26 June 2022

Biogenic amine hypothesis of affective disorders (English)

1 reference

https://api.crossref.org/works/10.1016/0024-3205(79)90208-X

26 June 2022

author name string

D. L. Garver

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A372718

26 June 2022

J. M. Davis

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A372718

26 June 2022

language of work or name

English

0 references

publication date

1 January 1979

1 reference

14 September 2017

29 January 1979

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=372718

full work available at URL

26 June 2022

https://api.elsevier.com/content/article/PII:002432057990208X?httpAccept=text/xml

1 reference

https://api.crossref.org/works/10.1016/0024-3205(79)90208-X

https://api.elsevier.com/content/article/PII:002432057990208X?httpAccept=text/plain

10 April 2023

1 reference

https://api.crossref.org/works/10.1016/0024-3205(79)90208-X

10 April 2023

1 reference

14 September 2017

volume

24

1 reference

14 September 2017

issue

5

1 reference

14 September 2017

page(s)

383-394

1 reference

Depression by reserpine of the noradrenaline concentration in the hypothalamus of the cat.

14 September 2017

cites work

2

1 reference

https://api.crossref.org/works/10.1016/0024-3205(79)90208-X

Serotonin release as a possible mechanism of reserpine action

10 April 2023

3

1 reference

https://api.crossref.org/works/10.1016/0024-3205(79)90208-X

10 April 2023

Pharmacological Reviews

15

16

179

Kopin

1964

1 reference

https://api.crossref.org/works/10.1016/0024-3205(79)90208-X

MONOAMINE OXIDASE INHIBITORS

10 April 2023

16

1 reference

https://api.crossref.org/works/10.1016/0024-3205(79)90208-X

A multiple-dose, controlled study of phenelzine in depression-anxiety states

10 April 2023

17

1 reference

https://api.crossref.org/works/10.1016/0024-3205(79)90208-X

The treatment of depressive states with G 22355 (imipramine hydrochloride).

10 April 2023

18

1 reference

https://api.crossref.org/works/10.1016/0024-3205(79)90208-X

INHIBITION OF UPTAKE OF TRITIATED-NORADRENALINE IN THE INTACT RAT BRAIN BY IMIPRAMINE AND STRUCTURALLY RELATED COMPOUNDS.

10 April 2023

21

1 reference

https://api.crossref.org/works/10.1016/0024-3205(79)90208-X

Inhibition of the uptake of tritiated catecholamines by antidepressant and related agents

10 April 2023

22

1 reference

https://api.crossref.org/works/10.1016/0024-3205(79)90208-X

Effects of tricyclic antidepressants on the uptake and metabolism of intracisternally administered norepinephrine-H3 in rat brain

10 April 2023

23

1 reference

https://api.crossref.org/works/10.1016/0024-3205(79)90208-X

The effect of imipramine-like drugs and antihistamine drugs on uptake mechanisms in the central noradrenaline and 5-hydroxytryptamine neurons

10 April 2023

24

1 reference

https://api.crossref.org/works/10.1016/0024-3205(79)90208-X

Antidepressant response to tricyclics and urinary MHPG in unipolar patients. Clinical response to imipramine or amitriptyline

10 April 2023

26

1 reference

https://api.crossref.org/works/10.1016/0024-3205(79)90208-X

Biogenic amines and depression. Biochemical and pharmacological separation of two types of depression

10 April 2023

27

1 reference

https://api.crossref.org/works/10.1016/0024-3205(79)90208-X

Plasma concentration of amitriptyline and clinical response

10 April 2023

29

1 reference

https://api.crossref.org/works/10.1016/0024-3205(79)90208-X

Quantitative determination of imipramine and desipramine in human blood plasma by direct densitometry of thin-layer chromatograms

10 April 2023

30

1 reference

https://api.crossref.org/works/10.1016/0024-3205(79)90208-X

Journal of Pharmacology and Experimental Therapeutics

10 April 2023

33

157

493

Rutledge

1967

1 reference

https://api.crossref.org/works/10.1016/0024-3205(79)90208-X

Metabolism of normetanephrine-H3 in rat brain--identification of conjugated 3-methoxy-4-hydrophenylglycol as the major metabolite

10 April 2023

34

1 reference

https://api.crossref.org/works/10.1016/0024-3205(79)90208-X

Journal of Pharmacology and Experimental Therapeutics

10 April 2023

35

177

600

Maas

1971

1 reference

https://api.crossref.org/works/10.1016/0024-3205(79)90208-X

Excretion of catecholamine metabolites following intraventricular injection of 6-hydroxydopamine in the Macaca speciosa

10 April 2023

36

1 reference

https://api.crossref.org/works/10.1016/0024-3205(79)90208-X

3-Methoxy-4-hydroxy phenylglycol (MHPG) excretion in depressive states. A pilot study

10 April 2023

38

1 reference

https://api.crossref.org/works/10.1016/0024-3205(79)90208-X

Norepinephrine metabolites as biochemical criteria for classifying depressive disorders and predicting responses to treatment: preliminary findings.

10 April 2023

39

1 reference

https://api.crossref.org/works/10.1016/0024-3205(79)90208-X

Antidepressant response to tricyclics and urinary MHPG in unipolar patients. Clinical response to imipramine or amitriptyline

10 April 2023

40

1 reference

https://api.crossref.org/works/10.1016/0024-3205(79)90208-X

Neuroendocrine and amine studies in affective illness

10 April 2023

42

1 reference

https://api.crossref.org/works/10.1016/0024-3205(79)90208-X

Journal of Pharmacology and Experimental Therapeutics

10 April 2023

43

158

213

Neff

1967

1 reference

https://api.crossref.org/works/10.1016/0024-3205(79)90208-X

Cerebrospinal fluid amine metabolites in affective illness: the probenecid technique

10 April 2023

44

1 reference

https://api.crossref.org/works/10.1016/0024-3205(79)90208-X

Acid monoamine metabolites of cerebrospinal fluid in mental depression and mania

10 April 2023

46

1 reference

https://api.crossref.org/works/10.1016/0024-3205(79)90208-X

Studies on sodium transfer and 5-hydroxyindoles in depressive illness

10 April 2023

47

1 reference

https://api.crossref.org/works/10.1016/0024-3205(79)90208-X

Abnormalities of indoleamines in affective disorders

10 April 2023

48

1 reference

https://api.crossref.org/works/10.1016/0024-3205(79)90208-X

Cerebrospinal fluid 5-hydroxyindoleacetic acid and homovanillic acid in psychiatric patients

10 April 2023

50

1 reference

https://api.crossref.org/works/10.1016/0024-3205(79)90208-X

Homovanillic and 5-Hydroxyindoleacetic Acid in Cerebrospinal Fluid of Depressed Patients

10 April 2023

52

1 reference

https://api.crossref.org/works/10.1016/0024-3205(79)90208-X

5-Hydroxyindole acetic acid and homovanillic acid in cerebrospinal fluid in manic-depressive psychosis and the effect of probenecid treatment

10 April 2023

55

1 reference

https://api.crossref.org/works/10.1016/0024-3205(79)90208-X

5-Hydroxyindoleacetic Acid Levels in the Cerebrospinal Fluid of Depressive Patients treated with Probenecid

10 April 2023

56

1 reference

https://api.crossref.org/works/10.1016/0024-3205(79)90208-X

Lumbar CSF 5-hydroxyindoleacetic acid and homovanillic acid in affective syndromes

10 April 2023

57

1 reference

https://api.crossref.org/works/10.1016/0024-3205(79)90208-X

"Serotonin Depression"—A Biochemical Subgroup Within the Affective Disorders?

10 April 2023

58

1 reference

https://api.crossref.org/works/10.1016/0024-3205(79)90208-X

Endogenous depressions with and without disturbances in the 5-hydroxytryptamine metabolism: A biochemical classification?

10 April 2023

60

1 reference

https://api.crossref.org/works/10.1016/0024-3205(79)90208-X

Effect of L-Tryptophan on Brain Serotonin Metabolism in Depressed Patients

10 April 2023

61

1 reference

https://api.crossref.org/works/10.1016/0024-3205(79)90208-X

Insulin tolerance test in depression.

10 April 2023

64

1 reference

https://api.crossref.org/works/10.1016/0024-3205(79)90208-X

Growth hormone catecholamines in affective disease

10 April 2023

66

1 reference

https://api.crossref.org/works/10.1016/0024-3205(79)90208-X

Reduced growth hormone responses to amphetamine in "endogenous" depressive patients: studies in normal, "reactive" and "endogenous" depressive, schizophrenic, and chronic alcoholic subjects

10 April 2023

67

1 reference

https://api.crossref.org/works/10.1016/0024-3205(79)90208-X

Human growth hormone response to levodopa. Relation to menopause, depression, and plasma dopa concentration

10 April 2023

69

1 reference

https://api.crossref.org/works/10.1016/0024-3205(79)90208-X

A PRELIMINARY INVESTIGATION OF STEROID EXCRETION IN DEPRESSED PATIENTS BEFORE AND AFTER ELECTROL-CONVULSIVE THERAPY

10 April 2023

72

1 reference

https://api.crossref.org/works/10.1016/0024-3205(79)90208-X

Cortisol production in depressive illness. A clinical and biochemical clarification

10 April 2023

73

1 reference

https://api.crossref.org/works/10.1016/0024-3205(79)90208-X

Adrenal cortical activity in depressive illness

10 April 2023

74

1 reference

https://api.crossref.org/works/10.1016/0024-3205(79)90208-X

Neuroendocrine regulation in depression. I. Limbic system-adrenocortical dysfunction

10 April 2023

76

1 reference

https://api.crossref.org/works/10.1016/0024-3205(79)90208-X

Adrenergic Blockade and the Corticosteroid and Growth Hormone Responses to Methylamphetamine

10 April 2023

79

1 reference

https://api.crossref.org/works/10.1016/0024-3205(79)90208-X

Parachlorophenylalanine Reversal of Tranylcypromine Effects in Depressed Patients

10 April 2023

80

1 reference

https://api.crossref.org/works/10.1016/0024-3205(79)90208-X

A cholinergic-adrenergic hypothesis of mania and depression

10 April 2023

81

1 reference

https://api.crossref.org/works/10.1016/0024-3205(79)90208-X

Depressive effects of physostigmine

10 April 2023

82

1 reference

https://api.crossref.org/works/10.1016/0024-3205(79)90208-X

Depression associated with oral choline

10 April 2023

83

1 reference

https://api.crossref.org/works/10.1016/0024-3205(79)90208-X

Effects of a dopamine agonist piribedil in depressed patients: relationship of pretreatment homovanillic acid to antidepressant response

10 April 2023

84

1 reference

https://api.crossref.org/works/10.1016/0024-3205(79)90208-X

Nomifensine: A potent dopaminergic agonist of antiparkinson potential

10 April 2023

85

1 reference

https://api.crossref.org/works/10.1016/0024-3205(79)90208-X

Controlled study comparing nomifensine and clomipramine in unipolar depression, using the probenecid technique

10 April 2023

87

1 reference

https://api.crossref.org/works/10.1016/0024-3205(79)90208-X

Cerebral monoamines and depression. An investigation with the Probenecid technique

10 April 2023

88

1 reference

https://api.crossref.org/works/10.1016/0024-3205(79)90208-X

Action of various antidepressant treatments reduces reactivity of noradrenergic cyclic AMP-generating system in limbic forebrain

10 April 2023

90

1 reference

https://api.crossref.org/works/10.1016/0024-3205(79)90208-X

Effect of Iprindole on Amine Uptake in Man

10 April 2023

96

1 reference

https://api.crossref.org/works/10.1016/0024-3205(79)90208-X

Effect of iprindole on norepinephrine turnover and transport

10 April 2023

97

1 reference

https://api.crossref.org/works/10.1016/0024-3205(79)90208-X

Some aspects of the cardiovascular pharmacology of UK 14,275 in patients with coronary artery disease

10 April 2023

100

1 reference

https://api.crossref.org/works/10.1016/0024-3205(79)90208-X

The effect of a tetracyclic antidepressant compound, Org GB94, on the turnover of biogenic amines in rat brain

10 April 2023

103

1 reference

https://api.crossref.org/works/10.1016/0024-3205(79)90208-X

Advances in biochemical psychopharmacology

10 April 2023

106

13

137

Schildkraut

1975

1 reference

https://api.crossref.org/works/10.1016/0024-3205(79)90208-X

Effect of ECT and imipramine treatment on the concentration of 5-hydroxyindoleacetic acid (5HIAA) and homovanillic acid (HVA) in the cerebrospinal fluid of depressed patients

10 April 2023

107

1 reference

https://api.crossref.org/works/10.1016/0024-3205(79)90208-X

Daily variations of the urine content of 3-methoxy-4-hydroxyphenylglycol in two manic-depressive patients.

10 April 2023

108

1 reference

https://api.crossref.org/works/10.1016/0024-3205(79)90208-X

Urinary Catecholamine Metabolites during Behavioral Changes in a Patient with Manic-Depressive Cycles

10 April 2023

109

1 reference

https://api.crossref.org/works/10.1016/0024-3205(79)90208-X

Inhibition of dopamine-b-hydroxylase in manic patients. A clinical trial and fusaric acid

10 April 2023

110

1 reference

https://api.crossref.org/works/10.1016/0024-3205(79)90208-X

Catecholamines and mania: The effect of alpha-methyl-para-tyrosine on manic behavior and catecholamine metabolism

10 April 2023

111

1 reference

https://api.crossref.org/works/10.1016/0024-3205(79)90208-X

Parasympathetic suppression of manic symptoms by physostigmine

10 April 2023

112

1 reference

https://api.crossref.org/works/10.1016/0024-3205(79)90208-X

10 April 2023

Identifiers

1 reference

release_uzataocakfhj7fwgdlqejvgdha

14 September 2017

Fatcat ID

0 references

1 reference